Novartis Cancels Vasella's $78M Golden Handshake

Feb. 19 (Bloomberg) -- Bloomberg Europe Business Editor Elliott Gotkine reports that Novartis and outgoing Chairman Daniel Vasella ended an agreement that would have paid him as much as $78 million to keep him from working for rival drugmakers. He speaks on Bloomberg Television's "The Pulse."